Maynard Um
-
-
-
-
-
-
-
Merck (MRK) Declares $0.85 Quarterly Dividend; 2.6% Yield
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Merck (MRK)
-
-
-
-
-
-
-
Merck reaches deal to expand HIV drug access via ADAP programs
-
-
-
-
-
-
-
FDA grants breakthrough therapy designation to Merck's KRAS G12C inhibitor
-
-
-
-
-
-
-
Merck publishes synthesis method for oral PCSK9 inhibitor in Science
-
-
-
-
-
-
-
Merck and Google Cloud announce $1 billion AI partnership
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Merck (MRK)
-
428,951 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

